The role of the CCR4-NOT complex and mRNA regulatory elements in determining protein synthesis, destination and complex formation.
The role of the CCR4-NOT complex and mRNA regulatory elements in determining protein synthesis, destination and complex formation.
批准号:
BB/W01713X/1
负责人:
Catherine Jopling
金额:
$52.55万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2023
资助国家:
英国
项目状态:
未结题
起止时间:
2023 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
While nearly all cells in an organism contain identical DNA, enormous differences in the behaviour of cells occur over the course of development and in different tissues. These differences are achieved by the regulation of gene expression, the process by which the DNA of a gene is copied to mRNA (transcription), and the mRNA is used as a template to make the encoded protein (translation). The network of proteins produced within a cell then dictates its function. Control of the production of the correct proteins in the right place at the right time is crucial in allowing cells to carry out their function and to respond rapidly to changes in environment. A central hub in this regulation is the CCR4-NOT protein complex. CCR4-NOT induces mRNA degradation, both globally and through targeted recruitment to specific mRNAs, and has additional functions in detecting ribosome pausing during the elongation stage of translation and modulating cotranslational assembly of protein complexes. microRNAs (miRNA) are a biologically and medically important family of small RNA molecules that induce mRNA degradation and translation repression by binding to sequence-specific sites in the 3'untranslated region (UTR) of mRNAs and directly recruiting CCR4-NOT. In addition, we have shown that liver-specific miR-122 has an unusual role in promoting hepatitis C virus (HCV) replication. CCR4-NOT also promotes HCV replication, while we have shown that the proteins eIF4A2 and DDX6 are directly recruited by CCR4-NOT and involved in miRNA regulation of both cellular targets and HCV. It remains unclear how CCR4-NOT integrates signals from miRNAs and ribosome pausing to control the production, location and assembly of proteins. This will be determined in this proposal.The endoplasmic reticulum (ER) is a network of membranes within eukaryotic cells where secreted and membrane proteins are synthesised. mRNAs that encode these proteins are directed to the ER where translation occurs. We have recently found that CCR4-NOT specifically regulates ribosome pausing on ER-targeted mRNAs, and that there are differences in miRNA repression at the ER and in the cytoplasm. HCV replication occurs in a membranous web derived from the ER, but it is not known whether miR-122 or CCR4-NOT regulation of HCV occurs in this location. In this proposal, we will use state-of-the-art approaches to determine how CCR4-NOT controls the level and location of proteins, mRNAs and miRNAs throughout the cell. This will be followed by detailed interrogation of the mechanisms by which CCR4-NOT and miRNAs regulate cellular and viral targets in the ER and cytoplasm. This study will provide an unprecedented global overview of the effects of CCR4-NOT and miRNAs on the whole cell and on a detailed molecular level. This will make an important contribution to the fundamental understanding the control of gene expression, while also providing new avenues to manipulate mRNA metabolism with considerable relevance to the emerging field of RNA therapeutics.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of microRNA biogenesis from long noncoding RNAs
-
批准号:BB/S003908/1
-
项目类别:Research Grant
-
资助金额:$58.55万
-
财政年份:2019
-
负责人:Catherine Jopling
-
依托单位:
MicroRNA-mediated regulation of viral replication
-
批准号:BB/F02360X/1
-
项目类别:Fellowship
-
资助金额:$105.57万
-
财政年份:2008
-
负责人:Catherine Jopling
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CCL2/CCR4在子宫内膜异位症疼痛中的作用及相关机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:陈萍
-
依托单位:
Tadalafil 调控 CCL22/CCR4 抑制乳腺癌肿瘤微
环境 MDSCs 招募/分化的分子机制研究
-
批准号:Y24H160108
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:潘琦
-
依托单位:
CCL17/CCR4轴调控细胞自噬介导T细胞淋巴瘤血管生成的作用机制研究
-
批准号:
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2024
-
负责人:--
-
依托单位:
CCL22/CCR4对头颈部鳞状细胞癌迁移及肿瘤微环境中免疫细胞浸润
的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘宇
-
依托单位:
CCL17/CCR4调控ERK/AP1/SRA信号通路促进小胶细胞极化参与脑出血后血肿清除的机制研究
-
批准号:82101536
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:邓水香
-
依托单位:
趋化因子受体CCR4识别拮抗剂配体的机制研究
-
批准号:32100988
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:颜微
-
依托单位:
CCL22/CCR4介导的淋巴窦内皮细胞定向诱导宫颈癌淋巴结转移的作用及其机制研究
-
批准号:82072884
-
项目类别:面上项目
-
资助金额:56.0万元
-
批准年份:2020
-
负责人:刘军秀
-
依托单位:
肿瘤相关巨噬细胞源性CCL22介导食管鳞癌CCR4/DGKα/FAK蛋白复合体组装减低顺铂抗肿瘤敏感性的作用机制研究
-
批准号:81972243
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:陈杰
-
依托单位:
CCR4控制调节性T细胞的空间分布及其对自身免疫性疾病的作用
-
批准号:31870871
-
项目类别:面上项目
-
资助金额:60.0万元
-
批准年份:2018
-
负责人:刘智多
-
依托单位:
基于敲减三阴性乳腺癌趋化因子受体CCR4的自封孔纳米羟基磷灰石材料的靶向治疗研究
-
批准号:81501537
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2015
-
负责人:刘莹
-
依托单位: